Biogen Inc (BIIB)
146.47
-0.92
(-0.62%)
USD |
NASDAQ |
Dec 20, 16:00
145.50
-0.97
(-0.66%)
After-Hours: 06:23
Biogen Cash from Investing (Quarterly): -1.181B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Pfizer Inc | -2.057B |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Sage Therapeutics Inc | 81.05M |
| Moderna Inc | 721.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 935.60M |
| Cash from Financing (Quarterly) | -6.60M |
| Free Cash Flow | 1.768B |
| Free Cash Flow Per Share (Quarterly) | 5.514 |
| Free Cash Flow to Equity (Quarterly) | 803.70M |
| Free Cash Flow to Firm (Quarterly) | 847.12M |
| Free Cash Flow Yield | 8.27% |